Determinants of persistent smoking among breast cancer survivors.

Autor:	Gali K; Hamburg Center for Health Economics (HCHE), University of Hamburg, Hamburg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Aryal S; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.; Department of Health Sciences, Faculty of Life Sciences, Hamburg University of Applied Sciences, Hamburg, Germany., Bokemeyer F; Institute for Medical Psychology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Oncology, Hematology with Section Bone Marrow, Transplantation, and Pneumology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany., Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany., Obi N; Institute for Medical Biometry and Epidemiology (IMBE), University Medical Center Hamburg-Eppendorf (UKE), Hamburg Germany.; Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Becher H; Heidelberg Institute of Global Health, University Hospital Heidelberg, Heidelberg, Germany., Chang-Claude J; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.; Division of Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany.
Jazyk:	angličtina
Zdroj:	Preventive medicine reports [Prev Med Rep] 2024 Oct 20; Vol. 48, pp. 102913. Date of Electronic Publication: 2024 Oct 20 (Print Publication: 2024).
DOI:	10.1016/j.pmedr.2024.102913
Abstrakt:	Introduction: While quitting cigarette smoking can improve cancer treatment outcomes, many cancer patients continue to smoke post-diagnosis. The aim of this study was to examine factors associated with persistent cigarette use in postmenopausal women diagnosed with breast cancer, a cancer not traditionally thought of as tobacco-related. Methods: We used data of breast cancer patients who were recruited into the MARIE Study (Mamma Carcinoma Risk Factor Investigation) in Germany between 2002 and 2005 and followed up in 2009. This analysis was based on 450 study participants who reported active cigarette smoking at the time of diagnosis and participated in the follow-up interview. Logistic regression analyses were conducted to examine the association of sociodemographic characteristics, health behaviors, medical factors, and cancer treatment types with persistent smoking behavior. Results: At an average of 5.9 years (SD = 1.2) after diagnosis, 244 (54.2%) breast cancer survivors were still smoking cigarettes at follow-up. A longer duration of smoking (OR = 1.04, 95% CI = 1.01-1.06) and smoking on average ≥10 cigarettes per day (OR = 1.52, 95% CI = 1.02-2.28) increased the likelihood of persistent smoking, whereas increasing age (OR = 0.94, 95% CI = 0.90-0.97) and high engagement in leisure time physical activity (≥62 MET-hrs/wk: OR = 0.55, 95% CI = 0.32-0.98) were associated with quitting. Conclusion: Smoking cessation programs in cancer care are needed. Specifically for breast cancer patients, tobacco treatment plans that include physical activity may be particularly helpful in quitting smoking cigarettes. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2024 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu